Week 5 Final Exam: NR546 NR-546

EXAM ELABORATIONS Aug 27, 2025
Loading...

Loading document viewer...

Page 0 of 0

Document Text

Week 5 Final Exam: NR546 / NR-546

(Latest Update 2025 / 2026) Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner | Questions and Answers | 100% Correct | Grade A - Chamberlain

Question:

Carbamazepine (Tegretol): MOA, indications, adverse, pearls

Answer:

MOA: glutamate voltage gated sodium and calcium channel blocker (Glu-CB)

indications: acute mania , mixed mood

adverse: GI effects, sedation, hyponatremia, neutropenia

rash (Stevens-Johnson Syndrome)

  • / 2

Question:

effective for atypical pain, such as fibromyalgia and diabetic neuropathy

Answer:

duloxetine (Cymbalta)

Question:

treats anxious depression smokers require an increased dose

Answer:

fluvoxamine (Luvox)

Question:

contraindicated in clients with a history of seizures (NDRI)

Answer:

bupropion (Wellbutrin)

Question:

treats both depression and anxiety disorders, ensure trial of higher dose before switching to a different medication

Answer:

venlafaxine (Effexor)

  • / 2

Download Document

Buy This Document

$30.00 One-time purchase
Buy Now
  • Full access to this document
  • Download anytime
  • No expiration

Document Information

Category: EXAM ELABORATIONS
Added: Aug 27, 2025
Description:

Week 5 Final Exam: NR546 / NR-546 (Latest Update) Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner | Questions and Answers | 100% Correct | Grade A - Ch...

Get this document $30.00